상세정보
- 상세정보
Cardio-Oncology Management of Toxicities in the Era of Immunotherapy [electronic resource]
Russo, Antonio
- 책이미지
-
- 도서 상세정보
- 서평쓰기
| 자료유형 | 단행본 |
|---|---|
| 개인저자 | Russo, Antonio.,editor. Maurea, Nicola.,editor. Farmakis, Dimitrios.,editor. Giordano, Antonio.,editor. |
| 단체저자명 | SpringerLink (Online service). |
| 서명/저자사항 | Cardio-Oncology [electronic resource] : Management of Toxicities in the Era of Immunotherapy / edited by Antonio Russo, Nicola Maurea, Dimitrios Farmakis, Antonio Giordano. |
| 판사항 | 1st ed. 2022. |
| 형태사항 | XIV, 122 p. 21 illus., 18 illus. in color:online resource. |
| 총서사항 | Current Clinical Pathology=2197-7828 |
| 총서부출표목 | Current Clinical Pathology, |
| 기본자료 저록 | Springer Nature eBook |
| 기타형태 저록 | Printed edition:9783030977436Printed edition:9783030977450Printed edition:9783030977467 |
| ISBN | 9783030977443 |
| 기타표준부호 | 10.1007/978-3-030-97744-3 |
| 내용주기 | 1. Background: Immunology and cancer -- 2. Available immunotherapy drugs in oncology -- 3. Immunotherapy adverse events -- 4. Pathophysiology of cardiac toxicity -- 5. Cardiac risk factors for immunotherapy -- 6. Diagnostic methods of cardiac immunotherapy damaging -- 7. Biomarkers of early cardiotoxicity -- 8. Management of Patients with Cardiac Toxicity: the point of view of the cardiologist -- 9. Management of patients with cardiac toxicity: the point of view of the oncologist -- 10. Future perspectives. |
| 요약 | The development of immunotherapy in oncology field has revolutionized the prognosis of many types of cancer. The immune checkpoint inhibitors target receptors whose inhibition increases the activity of immune system cells against tumor cells. In recent years, new immunotherapies have been studied and approved in a growing number of tumors including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC). This volume provides a complete and updated state-of-art review regarding the management of cardiovascular toxicities from new immunotherapies. The manuscript is divided into different sections starting from the relationship between cancer and immune system to let the reader understand the new molecular concepts under immunotherapy development. Subsequent chapters describe specifically the immunotherapy options in solid tumor treatment and the main features of the immuno-related cardiovascular complications. This volume is written by experts in the oncological and cardiovascular fields and aims to provide to clinicians who approach current cancer patients a useful tool to move through the paths of modern cardio-oncology. An important section would afford the most relevant interventions needed to manage the cardiac events, suggesting how to reduce their impact and effects on oncological outcomes. The text concludes by addressing future perspectives in the cardio-immunology field, discussing many aspects such as the early detection of cardiovascular damage and the potential role of liquid biopsy in new damage-related biomarkers discovery. |
| 일반주제명 | Oncology. Cardiology. Pathology. Internal medicine. Oncology. Cardiology. Pathology. Internal Medicine. |
| 바로가기 | URL |